Drs Khanani and Khoramnia review the case of a newly diagnosed nAMD patient who showed a rapid response in disease control after starting faricimab therapy.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.